Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects</p>
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
Luis Felipe Santos Menezes, Elias Ferreira Sabiá Júnior, Diogo Vieira Tibery, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 105
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 96
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 84
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
Valentina Franco, Meir Bialer, Emilio Perucca
Neuropharmacology (2021) Vol. 185, pp. 108442-108442
Closed Access | Times Cited: 57
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 52
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial
Estácio Amaro da Silva Júnior, Wandersonia Moreira Brito Medeiros, João Paulo Mendes dos Santos, et al.
Trends in Psychiatry and Psychotherapy (2022)
Open Access | Times Cited: 38
Cryo-EM: The Resolution Revolution and Drug Discovery
Taianá Maia de Oliveira, Lotte van Beek, Fiona Shilliday, et al.
SLAS DISCOVERY (2020) Vol. 26, Iss. 1, pp. 17-31
Open Access | Times Cited: 50
Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
Muhammad Yousaf, Dennis Chang, Yang Liu, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4961-4961
Open Access | Times Cited: 34
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)
Eduardo Rodriguez Almaraz, Nicholas Butowski
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 1, pp. 30-44
Open Access | Times Cited: 16
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 16
Multifaceted targets of cannabidiol in epilepsy: Modulating glutamate signaling and beyond
Pukar Khanal, Vishal S. Patil, Kunal Bhattacharya, et al.
Computers in Biology and Medicine (2024) Vol. 179, pp. 108898-108898
Closed Access | Times Cited: 6
The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Cláudia Carvalho, Maria Augusta Vieira‐Coelho
Pharmacological Research (2022) Vol. 181, pp. 106258-106258
Open Access | Times Cited: 24
Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
Mengya Wang, Huayuan Liu, Zegang Ma
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 23
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
Brooke Manning, Thomas R. Arkell, Amie C. Hayley, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 247-257
Open Access | Times Cited: 5
Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice
Yasaman Javadzadeh, Alexandra Santos, Mark S. Aquilino, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 466-466
Open Access | Times Cited: 4
Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study
Emanuele Cerulli Irelli, Adolfo Mazzeo, Roberto Caraballo, et al.
Epilepsia (2025)
Open Access
Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study
Margaret-Ann Tait, Daniel Costa, Rachel Campbell, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320756-e0320756
Open Access
Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
Ellen Hurley, Carolyn Ellaway, Alexandra Johnson, et al.
Epilepsia (2022) Vol. 63, Iss. 7, pp. 1736-1747
Open Access | Times Cited: 21
Cannabinoids and the eye
Michael T.M. Wang, Helen V. Danesh‐Meyer
Survey of Ophthalmology (2020) Vol. 66, Iss. 2, pp. 327-345
Closed Access | Times Cited: 27
Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances
Aaron Mark Farrelly, Styliani Vlachou, Konstantinos Grintzalis
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 8, pp. 3993-3993
Open Access | Times Cited: 26
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Arvind Kumar, Kayla Kindig, Shanlin Rao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation
Pankaj Singh Cham, Pankul Kotwal, Kuhu Sharma, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 2, pp. 221-229
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top